Qualified Person (QP) Services

Providing around the clock support, enabled by at least two QPs per assignment, delivering full continuity, and reduced risk.

Gradient Image

Maximize Compliance and Quality with ProPharma's Expert Support

Our expert team offers enhanced Quality Unit support, MIA and WDA licensing guidance, and GMP compliance, ensuring your products meet EU and UK regulations. Connect with a ProPharma expert today to maintain the highest levels of safety and consistency.

Qualified Person Services for EU and UK Markets

Companies that intend to manufacture or import medicinal products in the EU and UK require a Manufacturing and Import Authorization (MIA) license and a designated named Qualified Person (QP) to oversee the product quality throughout the supply chain. Acting as an extension of your organization, our QP consultants bring a deep understanding of GMP processes. They work with your tesam to ensure compliant manufacturing and/or importation of products in the EU and UK markets. Our global team of certified QPs have broad experience covering multiple types of formulations, complex supply chains, technical transfer projects, aseptic/sterile manufacturing, radiopharmaceuticals, biologics, ATMPs, and supply for clinical trials.

Medical technician walking down hallway
Lab techs working at a desk with tablet devices

Navigating Regulatory Requirements for Medicinal Products

Every organization in the life sciences industry is required to have a current and compliant quality system to ensure the safety and quality of all products and services. Quality assurance involves upholding the desired level of quality in your products throughout every stage of the process, from production to delivery to the patient.

ProPharma's quality assurance professionals enhance your internal capabilities to ensure the consistency and safety of products. Our team acts as an extension of your Quality Unit, utilizing a hands-on and risk-based approach to quickly improve quality and compliance while implementing practical solutions for your organization.

Enhancing Quality with Qualified Person Services

To procure, sell and distribute medicinal products in the EU and the UK markets you need a Wholesaler Dealer Authorization (WDA) and a Responsible Person (RP) named on the license. In the UK a WDA can also be utilized to import QP-certified medicinal products from the EU. In that case, you would need a Responsible Person (import). The RP is tasked with supervising the quality of the company's wholesale operation and takes on the primary responsibility for ensuring compliance with GDP regulations and maintaining the quality of the distributed products.

Our highly experienced RPs can act as contractors named on your, or a third-party's, WDA for both human and veterinary medicines under EU and UK Guidelines. If you are new to the EU/UK market we can help you in navigating the road from QMS  build, through the WDA application process, a successful inspection, and obtaining your very own WDA license.

Person looking at data on multiple computer monitors and laptop
Gradient Image

Specialized QP/RP/RPi Services

ProPharma's global team of certified experts have broad experience covering multiple types of formulations, complex supply chains, technical transfer projects, aseptic/sterile manufacturing, radiopharmaceuticals, biologics, ATMP's, market access and supply for clinical trials.

Our QP/RP/RPi services include

Partner icon

Partnering with your organization to lead or assist in obtaining the manufacturer’s import license and wholesale distributor license

Partnering with your organization to lead or assist in obtaining the manufacturer’s import license and wholesale distributor license

Read Less
Innovation icon

Providing strategic recommendations in addition to standard QP oversight. We will support your organization to reduce issues, delays, and costs in the manufacturing process

Providing strategic recommendations in addition to standard QP oversight. We will support your organization to reduce issues, delays, and costs in the manufacturing process

Read Less
Service icon

Helping organizations develop a flexible staffing model that caters to specific needs ranging from long-term lead assignments (named on the client's license) to interim support

Helping organizations develop a flexible staffing model that caters to specific needs ranging from long-term lead assignments (named on the client's license) to interim support

Read Less
Compliance

QP Declaration

QP Confirmation

QP Batch Certification

QP Declaration

QP Confirmation

QP Batch Certification

Read Less
Computer System Validation icon

Experience building Quality Management Systems (QMS) and providing full oversight of the QMS to maintain product quality in the distribution to pharmacies, hospitals, or other wholesalers

Experience building Quality Management Systems (QMS) and providing full oversight of the QMS to maintain product quality in the distribution to pharmacies, hospitals, or other wholesalers

Read Less
Commissioning, qualification, validation icon

Supply chain mapping and risk assessment thereof to comply with the Falsified Medicines Directive 2011/62/EU

Supply chain mapping and risk assessment thereof to comply with the Falsified Medicines Directive 2011/62/EU

Read Less
Woman using a dropper into a bottle

Experience in EU & UK

  • Import and Batch Certification services for ATMPs, Biologics, Radiopharmaceuticals, vaccines and small molecules for both IMP and commercial products in EU.
  • Import and Batch Certification services for commercial Oral Solid Dosage products. QP Oversight of all types of IMP imported to the UK from the EEA.

Support for Pharmaceutical Products & Services

Our QP/RP/RPi experts can support a variety of products for the pharmaceutical industry, including:

  • Tablets
  • Capsules, both hard and soft shell
  • Liquids, creams, and ointments, both sterile and non-sterile
  • Sterilization by filtration, irradiation, and ethylene oxide
  • API supplier auditing, both small and large molecule to EU GMP Part II/ ICH Q7
  • Excipient supplier auditing to IPEC-PQG guidelines
  • Packaging supplies auditing, covering leaflets, labels, cartons, foils & films, primary containers to GMP, and PS9000:2016
  • Contract analytical laboratory auditing to GMP and ISO 17025:2017
  • Storage and distribution warehouse auditing to GDP
  • ATMPs
  • Biologics
  • Radiopharmaceuticals
  • Vaccines
  • IMP
  • Commercial products
Business worker holding espresso cup and stack of papers looking forward
hand-pointing-to-data-on-a-paper-ss-1370206463-650x425

Interim Qualified Person (QP)

Companies that intend to manufacture, import, sell or distribute pharmaceutical products in the EU/UK require a MIA license and a designated Qualified Person (QP) to oversee the product quality, and ultimately certify each batch of medicinal product for being manufactured, tested and released in accordance with EU GMP and the documents submitted to the EU/UK authorities.

In certain instances, volumes or circumstances may not justify hiring a QP. In such situations our QPs act as an extension of your organization, bringing a deep understanding of Good Manufacturing Practice (GMP) processes. They work with your team to ensure compliant manufacturing and distribution of products in the EU/UK market.

Interim Responsible Person (RP/RPi) Services

Wholesaling of Medicinal Products and Active Pharmaceutical Ingredients Under GDP

Our team of extensively skilled QPs and RPs is ready to function as contractors listed on your or a third parties Wholesale Dealers Authorization for both human and veterinary medicines under European Guidelines 2013/C 343/01 human medicines and 2015/C 95/01 APIs for medicinal products for human use.

Woman in lab injecting test tubes

Complex Needs Require Custom Solutions

Unlock your organization's potential in the life sciences industry with ProPharma's specialized QP/RP/RPi services. Partner with our global team of certified experts to ensure compliance, enhance product quality, and streamline your manufacturing and distribution processes.

How to Successfully Launch Products with QMS and QP Certification

Reaching patients in the EU with needed medicinal products is a complex undertaking that not only requires knowledge of varied regulatory landscapes, companies must also man, the services of a...

Ensure Successful Batch Release, Regulatory Compliance with Experienced Qualified Persons

Streamlining a CMO’s manufacturing process helped ensure GMP compliance for EU batch release and USA inspection readiness. A contract manufacturing organization (CMO) needs to have a reliable quality...

Insider Talks - Tips From Qualified Persons for Successful Importation

Which are the roadblocks impacting successfully obtaining a MIA for EEA/UK Markets? You are in the process of obtaining an MA or CTA to bring your product to EEA/UK markets, which can be a complex...

Our QP's provide 360 degree support to ensure successful batch release, including coordination with other parties, and fair pricing for  additional but required activities.

Typically, the competition charges high price for everything outside of the standard program.

Our QP's provide 360 degree support to ensure successful batch release, including coordination with other parties, and fair pricing for  additional but required activities.

Typically, the competition charges high price for everything outside of the standard program.

News & Insights

WHO Issues Guidance on Antibiotic Pollution Control

December 19, 2024

WHO Issues Guidance on Antibiotic Pollution Control

WHO issues guidance to control antibiotic pollution from manufacturing, addressing environmental and global health impacts of antimicrobial resistance.

Nonclinical Drug Development: FDA Recommendations for Confirming an Ames Positive Finding

December 18, 2024

Nonclinical Drug Development: FDA Recommendations for Confirming an Ames Positive Finding

Explore FDA's recommendations on follow-up testing for Ames-positive drugs to support first-in-human clinical trials. Learn how to navigate FDA regulations and ensuring successful product development.

Navigating Market Access & Reimbursement Strategy for Medical Devices in Europe

December 17, 2024

Navigating Market Access & Reimbursement Strategy for Medical Devices in Europe

Explore the importance of market access and reimbursement strategies for medical devices and in vitro diagnostics (IVDs) in Europe. Learn how early planning and the new European HTAR can enhance the...

ProPharma Appoints Brian Tuttle as Chief Financial Officer

October 21, 2024

ProPharma Appoints Brian Tuttle as Chief Financial Officer

ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Names Dawn Sherman Chief Executive Officer

September 30, 2024

ProPharma Names Dawn Sherman Chief Executive Officer

Dawn Sherman rejoins ProPharma as CEO, bringing nearly 30 years of industry experience to lead the regulatory, clinical, and compliance services provider.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

ProPharma Receives 2024 CRO Leadership Award

June 13, 2024

ProPharma Receives 2024 CRO Leadership Award

ProPharma wins 2024 CRO Leadership Award for exceeding expectations in key categories, solidifying its position as a top global research consulting organization in the life sciences industry.

Infographic The Cost of Poor Project Management - ProPharma

June 10, 2022

The Cost of Poor Project Management

Project Management isn’t for the faint of heart. There is a shockingly high rate of project failure… but on the other hand, great project management can be a key differentiator that leads a company...

Infographic Successfully Passing MHRA Inspections for Overseas Manufacturing Sites - ProPharma

August 31, 2022

Successfully Passing MHRA Inspections for Overseas Manufacturing Sites

ProPharma offers GMP and GDP compliance services from clinical development to commercial distribution of the products' lifecycle. ProPharma’s Compliance and Quality team completed the first on-site...

Infographic Navigating the Generic Drug Application and Approval Process - ProPharma

October 4, 2021

Navigating the Generic Drug Application and Approval Process

Navigating the generic drug application and approval process can be challenging. From pre-filing through post-approval, find out exactly what needs to be done for your Abbreviated New Drug...

News & Insights

ProPharma Appoints Brian Tuttle as Chief Financial Officer

October 21, 2024

ProPharma Appoints Brian Tuttle as Chief Financial Officer

ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Names Dawn Sherman Chief Executive Officer

September 30, 2024

ProPharma Names Dawn Sherman Chief Executive Officer

Dawn Sherman rejoins ProPharma as CEO, bringing nearly 30 years of industry experience to lead the regulatory, clinical, and compliance services provider.

Previous Post Arrow Next Post Arrow
ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

ProPharma Receives 2024 CRO Leadership Award

June 13, 2024

ProPharma Receives 2024 CRO Leadership Award

ProPharma wins 2024 CRO Leadership Award for exceeding expectations in key categories, solidifying its position as a top global research consulting organization in the life sciences industry.

Previous Award Arrow Next Award Arrow
WHO Issues Guidance on Antibiotic Pollution Control

December 19, 2024

WHO Issues Guidance on Antibiotic Pollution Control

WHO issues guidance to control antibiotic pollution from manufacturing, addressing environmental and global health impacts of antimicrobial resistance.

Nonclinical Drug Development: FDA Recommendations for Confirming an Ames Positive Finding

December 18, 2024

Nonclinical Drug Development: FDA Recommendations for Confirming an Ames Positive Finding

Explore FDA's recommendations on follow-up testing for Ames-positive drugs to support first-in-human clinical trials. Learn how to navigate FDA regulations and ensuring successful product development.

Navigating Market Access & Reimbursement Strategy for Medical Devices in Europe

December 17, 2024

Navigating Market Access & Reimbursement Strategy for Medical Devices in Europe

Explore the importance of market access and reimbursement strategies for medical devices and in vitro diagnostics (IVDs) in Europe. Learn how early planning and the new European HTAR can enhance the...

Previous Post Arrow Next Post Arrow
Infographic The Cost of Poor Project Management - ProPharma

June 10, 2022

The Cost of Poor Project Management

Project Management isn’t for the faint of heart. There is a shockingly high rate of project failure… but on the other hand, great project management can be a key differentiator that leads a company...

Infographic Successfully Passing MHRA Inspections for Overseas Manufacturing Sites - ProPharma

August 31, 2022

Successfully Passing MHRA Inspections for Overseas Manufacturing Sites

ProPharma offers GMP and GDP compliance services from clinical development to commercial distribution of the products' lifecycle. ProPharma’s Compliance and Quality team completed the first on-site...

Infographic Navigating the Generic Drug Application and Approval Process - ProPharma

October 4, 2021

Navigating the Generic Drug Application and Approval Process

Navigating the generic drug application and approval process can be challenging. From pre-filing through post-approval, find out exactly what needs to be done for your Abbreviated New Drug...

Previous Resource Arrow Next Resource Arrow